Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1994-01-18
1995-02-14
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
424 2, 424406, 514557, 514578, 514724, 514811, 514974, 426 75, 426590, 426592, 426599, A61K 31045, A61K 31195
Patent
active
053893590
ABSTRACT:
Compositions containing L-aspartate or L-asparagine for use as additives to foods, soft drinks, vitamins, and the like are described. A method for preventing ethanol toxicity in a human subject is also provided.
REFERENCES:
patent: 3009859 (1961-11-01), Laborit
patent: 3876783 (1975-04-01), Gavrilescu et al.
patent: 4038421 (1977-07-01), Mendy et al.
patent: 4479974 (1984-10-01), Schenz
patent: 4593020 (1986-06-01), Guinot
patent: 4703045 (1987-10-01), Guinot
patent: 4738856 (1988-04-01), Clark
patent: 4870057 (1989-09-01), Chiapparelli et al.
patent: 4913923 (1990-04-01), Van Den Ouweland
patent: 4992282 (1991-02-01), Mehansho et al.
patent: 4997672 (1991-03-01), DeSimone et al.
patent: 5102910 (1992-04-01), Mittheiss et al.
patent: 5145707 (1992-09-01), Lee
patent: 5176934 (1993-01-01), Lee
patent: 5324516 (1994-06-01), Pek et al.
Crownover et al, The Journal of Pharmacology and Experimental Therapeutics, vol. 236, No. 3, pp. 574-579 (1985).
Scholz et al, Eur. J. Biochem., vol. 63, pp. 449-458 (1976).
Ylikahri et al, Metabolism, vol. 20, No. 6, pp. 555-567 (1971).
Berry et al, Eur. J. Biochem., vol. 89, pp. 237-241 (1978).
Lister et al, TINS, vol. 10, No. 6, pp. 223-225 (1987).
Suzdak et al, Science, vol. 234, pp. 1243-1246 (1986).
Corda et al, European Journal of Pharmacology, vol. 159, pp. 233-239 (1989).
Judd et al, Am. J. Psychiatry, vol. 141, No. 12, pp. 1517-1521 (1984).
Mezey, Biochemical Pharmacology, vol. 25, pp. 869-875 (1976).
Nuotto et al, Clin. Pharmacol. Ther., vol. 31, No. 1, pp. 68-76 (1981).
Menon et al, Life Sciences, vol. 37, pp. 2091-2098 (1985).
Alkana et al, Psychopharmacology, vol. 77, pp. 11-16 (1982).
Alkana et al, Psychopharmacology, vol. 55, pp. 203-212 (1977).
Gianoulakis, Experientia, vol. 45, pp. 428-435 (1989).
Hoek et al, The FASEB Journal, vol. 6, pp. 2386-2396 (1992).
Mitchell et al, Ann. Rev. Nutr., vol. 6, pp. 457-474 (1986).
Gullans et al WO/PCT 91/14435 (Oct. 3, 1991) GA. 115: 248120w.
Knight JPN 03052 810 (Mar. 7, 1991) GA. 115: 214851v.
Mudzhiri et al U.K. 2 198041 (Jun. 8, 1988) GA. 111: 72962y.
Brekhman et al Ger DE 3641495 (Jun. 9, 1988) GA. 110: 121412j.
Gavrilescu et al Embase Abstract of Agressologie (16/4): 253-356 (1975).
Poey et al Medline Abstract of Toxicol. Eur. Res. 1(5): 303-9 (1978).
Boucharlat et al. Medline Abstract of Ann Med Psychol 1(3): 394-400 Mar. 1992.
Miwon Co. Ltd.
Rose Shep K.
LandOfFree
Pharmaceutical preparation containing L-aspartate or L-asparagin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical preparation containing L-aspartate or L-asparagin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparation containing L-aspartate or L-asparagin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-285942